Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | 2027-10-28 (340 days left) |
| Published | 2026-09-30 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity RFA-MH-27-125. CFDA: 93.853, 93.242, 93.279
The buyer, the value, the full description and the link to the official notice are available with a free account.